NURO - Wondering why it's not up higher on this PR. Market cap is only 4 mil and they get 5 million right now from this deal. And GSK helps pay for development. That's huge also
"GSK Consumer Healthcare to pay NeuroMetrix $5M for the assets relating to Quell technology for markets outside the U.S and up to $21.5M, upon the achievement of certain development and commercialization milestones. "
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.